USPTO serial 79340855
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott J. Major
OXFORD SIMCELL LIMITEDCENTRE FOR INNOVATION AND ENTERPRISE,BEGBROKE SCIENCE PARK BEGBROKEOXFORDSHIRE OX5 1PF,| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science; cells for research and scientific purposes; cell culture reagents for scientific and research use; bacterial preparations, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use in the nature of biological preparations for use in industry and science; biological preparation for use in cell cultures, other than for medical or veterinary use; biological tissue cultures, other than for medical and veterinary use | ACTIVE | — |
| 005 | Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical and medical preparations for the treatment and prevention of infectious diseases, cancers, metabolic diseases, and neurological diseases; cells for medical and veterinary use; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; biological preparations for medical and veterinary use for the treatment and prevention of infectious diseases, cancers, metabolic diseases, and neurological diseases; biological tissue cultures for medical and veterinary use; biological tissue cultures of microorganisms for medical and veterinary use; diagnostic preparations and materials, namely diagnostic reagents for veterinary, medical and clinical medical use, diagnostic substances for medical purposes, diagnostic preparations for pharmaceutical use, diagnostic biomarker reagents for medical and veterinary purposes, diagnostic reagents for medical and veterinary use in in vivo and in vitro diagnosis, and diagnostic reagents for veterinary, medical and clinical medical use in the nature of biological markers for therapeutic or diagnostic use; diagnostic preparations for medical and veterinary purposes; in vitro diagnostic preparations for medical use | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing, scientific research advisory, technological advisory, advisory on scientific and technological research in the field of manufacturing processes and consultancy services in the field of microorganisms and cells, and bacterial therapy, and research and design relating thereto; scientific research; scientific analysis in the field of microorganisms and cells, and bacterial therapy; technical data analysis services, namely, technical research in the field of microorganisms and cells, and bacterial therapy; research and development in the field of microorganisms and cells; biological research; bacteriological research; scientific services in the nature of cell culture services for scientific and research purposes, for others relating to the isolation and cultivation of human cells; cell culture services for scientific and research purposes for others; cell culture services for scientific and research purposes for others, namely, cell separation research and cell separation technology research services; research and development in the field of bacterial therapy; design and development of medical diagnostic testing apparatus and reagents; scientific laboratory testing services; information, advice and consultancy services relating to the aforementioned | ACTIVE | — |
| 044 | Medical services; veterinary services; medical treatment services, namely, care for patients with, and prevention of, diseases using non-replicating cells; medical services relating to the treatment and processing of human cells; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical therapy services, namely, nutritional therapy services, stem cell therapy services, bacterial therapy services, intravenous therapy services, hormone therapy services, immunotherapy services, therapy for disease prevention and vaccine therapy services; medical analysis services relating to the treatment of persons, namely, analysis of human tissues for the purposes of medical care and disease prevention; diagnostic testing services, namely, medical, genetic and veterinary testing, for diagnostic or medical treatment purposes; diagnostic testing relating to human health, namely, medical and genetic testing for diagnostic or medical treatment purposes; information, advice and consultancy services relating to the aforementioned | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| May 7, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 17, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 17, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 16, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 22, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 16, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 16, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 12, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 31, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 31, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 11, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 11, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 11, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 5, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 7, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 7, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 7, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 14, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 27, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 27, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 30, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 29, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 20, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 24, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 20, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |